Company profile: RPS Diagnostics
1.1 - Company Overview
Company description
- Provider of rapid point-of-care (POC) screening to identify patients with infectious diseases.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to RPS Diagnostics
Enochian Biopharma
HQ: United States
Website
- Description: Provider of biotechnology, operating as a biotechnology company.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Enochian Biopharma company profile →
Prodesse
HQ: United States
Website
- Description: Provider of molecular diagnostic reagents for infectious disease applications, with three FDA 510(k) cleared products in the United States and two CE-marked products in Europe; products can be used with various nucleic acid extraction and real-time PCR.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Prodesse company profile →
TriPharm
HQ: United States
Website
- Description: Provider of pharmaceuticals as a privately held pharmaceuticals company.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full TriPharm company profile →
Calypte Biomedical
HQ: United States
Website
- Description: Provider of in vitro diagnostic tests; develops, manufactures, and distributes such tests primarily for diagnosis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Calypte Biomedical company profile →
Agenovir
HQ: United States
Website
- Description: Provider of novel antiviral therapeutics for diseases associated with viral reservoirs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Agenovir company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for RPS Diagnostics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to RPS Diagnostics
2.2 - Growth funds investing in similar companies to RPS Diagnostics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for RPS Diagnostics
4.2 - Public trading comparable groups for RPS Diagnostics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →